학술논문

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
Document Type
Article
Source
In: British Journal of Psychiatry. (British Journal of Psychiatry, 14 December 2023, 223(6):533-541)
Subject
Language
English
ISSN
14721465
00071250